CEACAM5 and familial pancreatic carcinoma: Several antigens have been explored as potential targets for vaccine-based treatment in pancreatic cancer including carcinoembryonic antigen (CEA) [105], MUC1 [106,107], and heat shock proteins (HSP) [108].